T-cell therapies market
The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo Roots Analysis has announced the addition of “ RegulatoryT-Cell (Tregs) Therapies Market ” report to its list of offerings. Given the various benefits offered, including high target specificity, customization potential and ability to generate immunological memory, regulatoryT-cell (Treg) therapies have garnered significant attention among key industry stakeholders for the treatment of various oncological and non-oncological disease indications. Tregs have been observed to be capable of acting through more than one mechanism of suppression, depending on tissue site, type of cell and activation ...